Genetic testing for eye disease is providing vital information about complex retinal diseases, especially when used to confirm a clinician?s diagnosis, according to a newly published study of such tests that were conducted over a five-year period.
Among patients with retinal disease, molecular testing can confirm a clinical diagnosis of hereditary disorders, identify carrier status and confirm or rule out the presence of a familial mutation in those without symptoms, according to a report in the February issue of Archives of Ophthalmology, one of the JAMA/Archives journals.
In a new report in the February 15th issue of G&D, Dr. Martin McMahon (UCSF) and colleagues present a novel mouse model of non-small cell lung cancer, which will serve as a useful tool to test the efficacy of novel chemotherapeutic drug therapies in the early stages of lung tumorigenesis.
Sweaty palms hover over the mouse, butterflies flutter in the stomach as the email inbox opens. Despite the wealth of scepticism towards online dating, these are the very real symptoms of cyber romance.
Stress hormone appears to have different functions short- and long-term, showing potential to help remedy post-traumatic stress syndrome.
The Center for Health and Gender Equity (CHANGE) today called on UN agencies, major foundations and bilateral aid programs such as PEPFAR, the President’s Emergency Plan for AIDS Relief, to immediately increase funding for the procurement and distribution of female condoms in countries heavily affected by HIV/AIDS, as well as funding for programs that raise public awareness of female condoms and provide education on their use.
A robotic therapy device may help people regain strength and normal use of affected hands long after a stroke, according to a University of California, Irvine study.
Researchers have developed a small-molecule inhibitor of a protein that plays key roles in the control of cell division, and they show that the inhibitor can halt the growth of tumors in mice and cancer-derived cells growing in culture.
Identifying new medications and providing foolproof cancer diagnosis are two benefits anticipated from research by a team of engineering professors at the University of Houston.
Type II bipolar disorder is an underdiagnosed disease which can be easily confused with depression.